Pay in 4 interest-free payments of $21.25 Learn more
Ships within 48 hours · Estimated delivery Jul 29 - Aug 3
at a density of 1×104/well
24)/t8-/m0/s1
selective and orally bioavailable GPR40 (FFA1) agonist
2015 May 14
InChi: InChI=1S/C16H14O6/c1-21-13-3-2-8(4-10(13)18)14-7-12(20)16-11(19)5-9(17)6-15(16)22-14/h2-6
Tegaserod maleate Catalog No.:M8408-10 at a density of 1×104/wellTegaserod, also known as SDZ HTF 919; HTF 919 is a 5 HT4 agonist for the management of irritable bowel syndrome and constipation. Approved by the FDA in 2002, it was subsequently removed from the market in 2007 due to FDA concerns about possible adverse cardiovascular effects. Before then, it was the only drug approved by the United States Food and Drug Administration to help relieve the abdominal discomfort, bloating, and constipation associated with
US$ 290.00
US$ 400.00
US$ 1090.00
US$ 600.00
US$ 410.00